A Study of TY-2699a in Patients With Locally Advanced or Metastatic Solid Tumors

NCT05866692 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

156

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor, Adult

Interventions

DRUG: TY-2699a

Sponsor

TYK Medicines, Inc